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Abstract  
Sarcolemmal   membrane   fragility   is   a   major   contributor   to   the   pathology   of   various  
muscular  dystrophies,  including  Duchenne  Muscular  Dystrophy  (DMD).  DMD  is  a  fatal  X-­
linked  genetic  disorder  resulting  from  a  loss  of  the  dystrophin  protein.  This  causes  muscle  
degeneration  and  weakness,  in  both  skeletal  and  cardiac  tissue.  Muscle  fibers  with  more  
fragile  membranes  experience  a  higher  degree  of  damage  and  are  more  prone  to  necrotic  
cell   death.   Increasing   the   membrane   repair   capacity   of   these   fibers   can   serve   as   a  
potential   therapeutic   by   effectively   restoring   the   barrier   function   of   the   damaged  
membrane  and  prevent  muscle  fiber  death  and  muscle  loss.    One  strategy  to  increase  
the  membrane  repair  capacity  is  to  expose  the  muscle  fibers  to  Poloxamer  188  (P188),  a  
polymer   with   affinity   to   exposed   hydrophobic   lipid   chains   that   can   reseal   membrane  
wounds.  P188  is  part  of  a  family  of  poloxamers,  all  of  which  contain  a  hydrophobic  region  
of  polyoxypropylene  flanked  by  two  hydrophilic  chains  of  polyoxyethylene.  These  regions  
vary  in  length  between  different  poloxamers.  Although  P188  has  shown  promising  results  
in   membrane   repair,   other   poloxamers   in   this   family   have   not   been   tested   for   their  
membrane  sealing  capacity.  It  is  hypothesized  that  other  poloxamers  in  the  P188  family  
such  as  F38,  P84,  and  P407  will  reseal  membrane  wounds  as  or  more  effectively  than  
P188.    
To  investigate  this  hypothesis,  we  used  both  a  rotation  damage  assay  and  a  laser  injury  
assay  to  examine  the  repair  efficiency  of  poloxamers  on  in  vitro  human  embryonic  kidney  
(HEK293)  cells  and  ex  vivo  muscle  fibers  isolated  from  mdx  mice.  Studying  the  effect  of  
these  compounds  on  muscle  fibers  with  compromised  membrane  integrity  allowed  for  the  
evaluation  of  these  poloxamers  as  potential  therapeutic  agents  for  muscular  dystrophy.  
The  conclusion  of  these  assays  indicates  that  there  are  poloxamers  other  than  P188  that  
can  improve  the  repair  capacity  in  both  HEK293  cells  and  dystrophic  mdx  muscle  fibers.      
      
Introduction  
Muscular  dystrophies  come  in  a  variety  of  forms,  all  characterized  by  muscle  weakness  
and   degeneration.   One   of   the   most   common   and   most   severe   forms   of   muscular  
dystrophy   is   Duchenne   Muscular   Dystrophy   (DMD)   (1).   DMD   is   a   genetic   disorder  
affecting   one   in   every   3,500   to   5,000   males   (2).   Affected   individuals   display   severe  
muscle  weakness  in  early  development,  indicated  by  delays  in  sitting  up  and  walking.  In  
their   early   teens,   patients   often   experience   heart   and   lung   problems,   resulting   from  
muscle  weakness   in   the   heart,   diaphragm,   and   other  muscles   surrounding   the   lungs.  
DMD  is  a  fatal  disease,  but  with  the  advancement  of  respirators  the  life  span  of  affected  
individuals  can  extend    into  their  30s  and  40s  (3).    
Duchenne   Muscular   Dystrophy   is   an   X-­linked,   recessive   disorder,   resulting   from  
mutations  in  the  DMD  gene.  The  DMD  gene  encodes  dystrophin,  a  protein  that  forms  a  
complex   to  help  stabilize   the  cytoskeleton  and   form  connections  with   the  extracellular  
matrix  (2,4).  Large  disruptions  of  this  protein  are  thought  to  lead  to  nonsense-­mediated  
decay,   and   complete   loss   of   the   dystrophin   protein   (5).   Loss   of   this   protein   causes  
increased  sarcolemmal  membrane  fragility,  leaving  cells  susceptible  to  tears  caused  by  
muscle   contraction.   Muscle   fibers   are   typically   able   to   reseal   membrane   disruptions  
through  an  inherent  Ca2+-­mediated  repair  system,  in  which  vesicles  fuse  to  the  injury  site  
to  form  a  patch  that  restores  the  barrier  function  of  the  sarcolemma  (6–8).  In  DMD,  the  
membrane  repair  response  fails  to  keep  up  with  the  increase  in  mechanical  damage,  and  
this  damage  ultimately   results   in  uncontrolled   ion   influx  and  cell  death   (9).  A  potential  
therapeutic  technique  is  to  improve  the  membrane  repair  response,  thus  allowing  cells  to  
more  effectively  recover  from  damage.  One  way  to  enhance  membrane  repair  is  through  
exposure  to  Poloxamer  188  (P188).    
P188   is  a  member  of  a   family  of  poloxamers,  all  of  which  have  been  approved  by  the  
FDA.  Poloxamers  are  synthetic  copolymers,  made  up  of  two  hydrophilic  polyoxyethylene  
chains  flanking  a  hydrophobic  polyoxypropylene  chain  (10)  (Fig  1A).  These  chains  vary  
in  size  between  different  poloxamers.  These  differences  can  be  visualized  through  the  
use  of  a  poloxamer  grid,  where  poloxamers  are  categorized  based  on  the  weight  of  their  
polyoxypropylene  (POP)  chain  on  the  y-­axis,  and  the  %  weight  of  their  polyoxyethylene  
(POE)  chains  on  the  x-­axis  (Fig  1B).  Poloxamers  have  many  everyday  uses,  and  can  be  
found  in  products  such  as  moisturizers,  makeups,  hair  conditioners,  and  mouthwashes  
(11).  Certain  poloxamers  have  also  been  studied   in  medical  applications.  Specifically,  
P407  has  suggested  applications  in  drug  delivery  and  as  a  scaffold  for  tissue  engineering  
(12).   P407   has   also   been   used   in   combination   with   P181   to   increase   expression   of  
plasmid  DNA  when  used  in  delivery  to  skeletal  muscle  cells  (13).    
P188   is   the   most   common   poloxamer   used   in   biomedical   applications.   It   has   been  
extensively   studied   because   of   its   ability   to   improve   cell   membrane   repair.   This  
characteristic  has  been  observed  for  more  than  20  years,  since  P188  was  first  recognized  
for   its  ability   to  reseal   tissue  after  electrical   injury  (14).   It  has  since  been  tested   in   the  
repair  of  multiple  cell  types  following  various  types  of  injuries  (15,16).  Specifically,  P188  
has  been   shown   to   improve   repair   of   alveolus   cells   in   injured   lungs  and  muscle   cells  
following   irradiation   (17).   It   also   has   been   noted   for   its   ability   to   improve   survival   of  
neurons  following  both  mechanical  and  ischemia/reperfusion  injury  (18,19).  More  recent  
studies  indicate  that  administration  of  P188  in  vivo  can  alleviate  symptoms  in  models  of  
Duchenne  Muscular  Dystrophy.  These  findings  suggest  that  P188  has  a  protective  effect  
on   skeletal   muscle   when   delivered   subcutaneously,   and   on   cardiac   muscle   when  
delivered   intravenously   (9,20–22).   While   the   mechanism   of   this   improved   repair   is  
unknown,   it   is   hypothesized   that   P188   functions   by   directly   incorporating   into   the  
membrane  (23).  
Despite  their  structural  similarities  to  P188,  other  poloxamers  remain  largely  untested  in  
terms  of  membrane  repair  effects.  This  project  examined  a  subset  of  these  poloxamers  
to  determine  their  effects  on  membrane  repair.  I  hypothesize  that  multiple  poloxamers  in  
the  P188  family  will  improve  membrane  resealing  in  multiple  cell  types  as  effectively  as  
P188.   Poloxamers   P181,   P182,   P234,   P124,   P407,   P338,   P188,   and   P108   were   all  
selected  for  analysis  (Fig  1C).  These  poloxamers  were  chosen  to  best  represent  the  wide  
range  of  poloxamers  that  are  produced.  This  allows  us  to  compare  changes  in  membrane  
resealing  capacity  between  large  and  small  poloxamers,  and  assess  the  effect  of  different  
POP  and  POE  weight  ratios.    
  












Cell  Culturing:  Human  embryonic  kidney  cells  (HEK293)  were  purchased  from  American  
Type  Culture  Collection  (ATCC).    The  cells  were  cultured  at  37oC  and  5%  CO2  in  complete  
medium  composed  of  Dulbecco’s  Modified  Eagle’s  Medium  (DMEM),  10%  fetal  bovine  
serum,  (FBS)  and  1%  penicillin–streptomycin  (P–S).    Cells  were  split  onto  new  plates  at  
90%  confluency  and  used  for  examination  until  passage  25.    
Rotation  Damage  Assay:  1  x  105  HEK293  cells  in  500µL  of  complete  DMEM  were  added  
to  2mL  microcentrifuge  tubes  and  incubated  for  18  hours.  This  allowed  cells  to  adhere  to  
the  bottom  of  the  tube.  Cells  were  rinsed  with  500µL  PBS  before  adding  the  necessary  
reagents  to  each  group.  Each  group  contained  three  tubes  of  HEK293  cells.  200µL  of  1%  
Triton  in  PBS  was  added  to  one  group,  in  order  to  lyse  the  cells.  This  was  the  maximum  
control.  Tubes  used  for  the  15  rotation  and  no  rotation  controls  received  200µL  Tyrode’s  
solution  with  2mM  Ca2+.  The  remainder  of  the  tubes  served  as  experimental  groups  for  
various  poloxamers.  In  these  tubes,  200µL  Tyrode’s  solution  with  2mM  Ca2+  was  added  
with  the  addition  of  100µM  poloxamer.  30µL  glass  beads  (≥106µm)  were  added  to  each  
tube  except  for  the  no  rotation  control,  and  tubes  with  beads  were  rotated  360°  15  times,  
at  a  rate  of  ~4  seconds  per  revolution.  As  the  tubes  rotated,  the  beads  impacted  the  cells  
at  the  bottom  of  the  tube,  resulting  in  injury  to  the  cell  membranes.  After  rotating,  15µL  
supernatant  was  removed  from  each  tube,  and  added  to  a  96  well  plate  in  duplicate.  The  
relative  lactate  dehydrogenase  (LDH)  concentrations  were  measured  using  colorimetry  
of  the  reduction  reaction  between  NAD+  to  NADH  in  the  presence  of  L-­lactate  at  490nm.  
Absorbance   values  were   normalized   to   the   values   obtained   from   supernatant   of   cells  
lysed  with  1%  Triton.  
Laser  Injury  Assay:  Extensor  digitorum  longus  (EDL)  muscles  were  dissected  from  mdx  
mice.  Muscles  were  adhered  to  a  35mm  glass  bottom  plate,  and  submerged  in  500µL  
Tyrode’s   solution   containing   2mM   Ca2+,   100µM   poloxamer,   and   2.5µM   FM4-­64   dye  
(ThermoFisher-­T13320).   Muscle   fibers   were   imaged   individually   using   an   Olympus  
Multiphoton  FV1000  microscope.  A  UV   laser  was  used  to  vaporize  an  area  of   the  cell  
membrane,  with  a  size  of  about  0.9µm  x  0.9µm.  Images  were  taken  every  1.5  seconds  
for  a  period  of  60  seconds,  with  the  first  three  frames  captured  prior  to  injury.  Data  was  
analyzed  using   ImageJ  software  by  measuring   fluorescence   intensity  at   the   injury  site  
and  calculating  the  change  in  fluorescence  intensity  over  time.  The  fluorescence  intensity  
is  normalized  to  the  background  intensity  in  each  image  (ΔF/F0).  
Membrane  resealing  in  HEK293  cells  was  also  assessed  through  laser  injury.  Cells  were  
cultured  overnight  to  about  80%  confluence,  and  washed  with  1mL  PBS.  2mL  of  Tyrode’s  
solution  containing  2mM  Ca2+,  100µM  poloxamer,  and  2.5µM  FM4-­64  dye  was  added  to  
the  cell  plate,  and  the  cells  were  damaged,  imaged,  and  analyzed  similarly  to  EDL  muscle  




A  novel  rotation  damage  assay  was  used  to  examine  the  membrane  resealing  effects  of  
various  poloxamers  in  the  P188  family.  In  this  assay,  human  embryonic  kidney  (HEK293)  
cells  are  damaged  through  rotation  in  the  presence  of  small  glass  beads.  These  beads  
impact  the  cells,  causing  injury  to  the  cell  membranes.  This  damage  leads  to  release  of  
LDH  into  the  cell  supernatant.  LDH  is  typically  confined  inside  the  cell,  only  released  after  
membrane  damage  or  cell  death.  Since  injury  to  cells  is  consistent  in  each  tube,  changes  
in  the  amount  of  LDH  in  the  supernatant  indicate  changes  in  membrane  repair  capacity.  
Membrane   repair   is  a  Ca2+  dependent  process,   therefore  cells  were  also  damaged   in  
Tyrode’s  solution  containing  0mM  Ca2+   to  confirm   the  validity  of  using  LDH  release   to  
measure  membrane  repair  capacity.  All  groups  were  normalized  to  the  supernatant  from  
cells  lysed  with  1%  triton,  which  represented  maximum  LDH  release.  To  investigate  the  
impact  of  poloxamers  on  membrane  repair,  cells  were  damaged  in  the  presence  of  100µM  
poloxamer.  A  diagram  and  results  of  the  rotation  damage  assay  are  shown  in  figure  2.    
Based   on   the   results   of   the   rotation   damage   assay,   P188   significantly   reduced   LDH  
release  from  injured  cells,  indicating  improved  membrane  repair  capacity  in  HEK293  cells  
when  compared   to  a  no  poloxamer  control.  Poloxamers  P182,  P108,  P234,  and  P124  
also   improve   membrane   repair   when   compared   to   cells   damaged   in   the   absence   of  
poloxamer.  However,  none  of  these  poloxamers  improve  membrane  repair  significantly  
more  than  P188.  Poloxamers  P181,  P338,  and  P407  led  to  no  significant  improvement  in  
membrane  repair  capacity  in  HEK293  cells  when  compared  to  the  15  rotation  control.  
A  laser  injury  assay  was  used  to  examine  the  effects  of  the  same  group  of  poloxamers  
when  applied  to  mdx  muscle  fibers.  For  this  assay,  EDL  muscles  were  dissection  from  
mdx  mice  and  submerged  in  Tyrode’s  solution  containing  2mM  Ca2+  and  2.5µM  FM4-­64  
Dye.  FM4-­64  is  a  lipophilic  dye  that  fluoresces  when  it  comes  in  contact  with  the  inner  
leaflet  of   the  cell  membrane.   Individual  muscle   fibers  are  damaged  with  a  multiphoton  
laser,  allowing  FM4-­64  to  come  in  contact  with  the  inner  leaflet  and  fluoresce.  The  fiber  
is  imaged  before,  during,  and  after  injury,  and  the  change  in  fluorescence  is  measured  
over  time.  This  fluorescence  is  normalized  to  the  background  fluorescence  in  each  image.  
Muscles  were  also   injured   in  Tyrode’s   solution  with  0mM  Ca2+   to   confirm   the  assay’s  
measurement   of   membrane   resealing.   100µM   poloxamer   was   added   to   the   Tyrode’s  
solution  to  measure  the  effects  of  poloxamers  on  membrane  resealing  capacity  in  muscle  
fibers.  Results  and  representative  images  from  laser  injury  in  muscle  fibers  are  shown  in  
Figures   3   and   4.  Curves   depicting  ΔF/F0   over   time   for   each   poloxamer   are   shown   in  
figures  3A  and  4A.  For  each  curve,  area  under  the  curve  (AUC)  was  calculated.  The  AUC  
for  each  curve  is  shown  in  figures  3B  and  4B.    
Figure   3   shows   laser   injury   results   of   poloxamers  with   less   than   50%   of   their   weight  
consisting  from  the  POE  segments  (P181,  P182,  P234,  P124).  This  set  of  poloxamers  
possess  mostly  hydrophobic  properties  due  to  the  majority  of  their  weight  is  comprised  of  
POP  chain.  Results  of  the  laser  injury  show  that  muscle  fibers  injured  in  the  presence  of  
100µM  of  each  respective  poloxamer  had  significantly  less  FM4-­64  dye  fluorescence  after  
injury  when  compared   to  muscle   fibers   injured   in   the  absence  of  any  poloxamer.  This  
suggests  that  all  of  these  poloxamers  improve  membrane  repair  capacity  in  mdx  muscle  
fibers.    
Figure  4  shows   laser   injury   results  of  poloxamers  with  more   than  50%  of   their  weight  
made  up  of  POE  (P188,  P407,  P338,  P108).  These  poloxamers  are  more  hydrophilic,  
since  most  of  their  weight  is  composed  by  the  POE  chains  on  either  end  of  the  polymer.  
Results  of  the  laser  injury  assay  reveal  that  out  of  this  group  of  poloxamers,  only  P188  
and  P407  lead  to  a  significant  improvement  in  membrane  repair  capacity  of  mdx  muscle  
fibers.  Analysis  by  ANOVA  indicates  that  none  of  the  poloxamers  investigated  as  part  of  
this  project  improved  membrane  repair  significantly  better  than  P188.      
Interestingly,   some   poloxamers   affected  membrane   repair   differently   in   the   two   injury  
assays  used  as  part  of  this  project.  For  example,  P108  significantly  improved  membrane  
repair  capacity  in  HEK293  cells  when  investigated  using  the  rotation  damage  assay,  but  
had  no  effect  on  membrane  repair  when  applied  to  muscle  fibers  in  the  laser  injury  assay.  
Conversely,  P407  and  P181  had  no  effect  when  examined  in  the  rotation  damage  assay  
with  HEK293  cells,  but  muscle  fibers  injured  in  the  presence  of  each  of  these  poloxamers  
showed   significant   improvement   in   membrane   repair.   These   differences   could   be  
explained   in   two  ways.  First,   the  specificity  of   these  poloxamers   is  due   to   the   type  of  
membrane   damage   induced   (assay   dependent)   or   they   are   selective   to   different   cell-­
types.    
To  distinguish  if  the  poloxamers  function  in  a  cell  type  or  wound  type  manner,  the  repair  
capacity  of  HEK293  exposed  to  these  poloxamers    were  analyzed  through  the  laser  injury  
assay.  This  is  done  using  the  same  technique  described  above,  however,  using  HEK293  
cells  rather  than  muscle  fibers.  The  results  of  these  experiments  are  displayed  in  Figure  
5.  P108  was  chosen  for  examination  because  it  is  one  of  the  poloxamers  that  had  different  
effects   in   the   laser   injury  and   rotation  damage  assays.  The   results  of   this   laser   injury  
assay  indicate  that  exposure  to  100µM  P108  leads  to  a  significant  decrease  in  FM4-­64  
fluorescence  after  injury  to  HEK293  cells.  Since  exposure  to  P108  improves  membrane  
repair   in  HEK293  cells   in  both   the   rotation  damage  and   the   laser   injury  assays,   these  





The  primary  goal  of  this  project  was  to  identify  other  poloxamers  in  the  P188  family  with  
the   ability   to   improve  membrane   resealing   capacity.   If   other   poloxamers   have   effects  
similar   to   those   of   P188,   these   poloxamers   may   have   potential   as   therapeutics   for  
diseases  such  as  Duchenne  Muscular  Dystrophy.    
Results   suggest   that   a   number   of   poloxamers   improve  membrane   repair   in   both   the  
rotation   damage   assay,   performed   with   HEK293   cells,   and   the   laser   injury   assay,  
performed   with   muscle   fibers.   These   are   poloxamers   P182,   P124,   P234,   and   P188.  
Poloxamers  P182,  P124,  and  P234  all  have  weights  consisting  of  less  than  50%  POE.  
This  makes  these  poloxamers  more  hydrophobic  and  giving  them  a  strong  affinity  for  the  
lipids  that  are  exposed  after  damage  occurs  to  a  cell  membrane.  P188  has  more  than  
50%  POE  by  weight,  making  it  a  more  hydrophilic  molecule.  However,  the  number  of  POP  
repeats   in   P188   is   within   the   same   range   of   P182,   P124,   and   P234.   Each   of   these  
poloxamers  has  between  20  and  41  POP  repeats.  Each  of  these  poloxamers  also  has  
between  8  and  80  POE  repeats.  P182  has  the  smallest  number  of  POE  repeats  with  8,  
and  P188  has  the  most  repeats  with  80  (24).  
Poloxamer  P108  was  the  only  polymer  to  improve  membrane  resealing  in  HEK293  cells,  
but  not   in  muscle   fibers.  As  previously  mentioned,   the   results   summarized   in   figure  5  
suggest   that   this   difference   is   a   result   of  P108  having   cell-­type   specific   effects.  P108  
consists   of   43  POE   repeats,   and   only   15  POP   repeats,  making   this   poloxamer  more  
hydrophilic.  While  the  number  of  POE  repeats  falls  in  the  same  range  as  the  poloxamers  
that  improved  membrane  repair  in  both  cell  types,  P108  has  the  smallest  number  of  POP  
repeats  out  of  all  poloxamers  tested.  One  explanation  could  be  that  the  POP  segment  is  
too   small   and  has  a   less   robust   affinity   to   the  hydrophobic   lipid   chains   in   the  plasma  
membrane.    Because  the  membrane  of  HEK293  cells  have  a  large  surface  area  directly  
exposed  to  the  solution,  poloxamers  with  less  attraction  to  membrane  wounds  can  still  
bind  and  restore  the  cell’s  barrier  function.  However,  in  mdx  muscle  fibers,  which  exhibit  
compromised  membrane  repair  and  stability,  it  may  be  more  important  to  have  a  longer  
hydrophobic  chain  that  can  seal  a  membrane  with  more  exposed  lipids  after  injury.  
Poloxamers  P181  and  P407  each  improved  membrane  resealing  in  mdx  muscle  fibers,  
but  not  in  HEK293  cells.  P181  has  the  smallest  molecular  weight  of  all  poloxamers  tested,  
and  consists  of  30  POP  repeats,  and  only  3  POE  repeats.  This  composition  makes  P181  
a   mostly   hydrophobic   polymer.   With   such   short   POE   chains,   it   is   possible   that   this  
poloxamer  has  a  very  low  affinity  for  the  hydrophilic  region  of  an  injured  cell  membrane,  
which  may  affect  its  ability  to  improve  resealing  capacity  of  HEK293  cells.  P407  is  one  of  
the  largest  poloxamers  tested,  consisting  of  101  POE  repeats  and  56  POP  repeats.  This  
composition  makes  this  poloxamer  more  hydrophilic.  The  large  number  of  POP  repeats  
may  make   the   hydrophobic   region   too   large   to   incorporate   into   a   normal   injured   cell  
membrane.  However,  this  large  POP  region  may  make  this  more  effective  in  resealing  
injuries  that  occur  to  cells  with  a  membrane  repair  defect  or  less  membrane  integrity.  This  
would  explain  why  P407  was  effective   in   improving   resealing  capacity  of  mdx  muscle  
fibers,  but  not  in  HEK293  cells.  
Of  all  poloxamers  tested,  only  P338  had  no  effect  on  membrane  repair  capacity  in  either  
cell  type.  P338  has  the  largest  molecular  weight  of  all  poloxamers  tested,  consisting  of  
132  POE  repeats  on  either  side  of  the  polymer,  and  only  51  POP  repeats  in  the  center.  
This  is  the  largest  number  of  POE  repeats  of  all  poloxamers  tested,  and  it’s  possible  that  
these  large  hydrophilic  chains  hinder  the  poloxamer’s  ability  to  reseal  membrane  wounds.    
  
While  this  project  provides  a  preliminary  investigation  into  the  membrane  resealing  effects  
of   multiple   poloxamers,   more   research   is   required   to   understand   these   poloxamers’  
potential  as  therapeutics  for  diseases  such  as  muscular  dystrophy.  Past   investigations  
into  the  effects  of  P188  have  used  a  number  of  experiments  that  could  be  useful  when  
looking   at   additional   poloxamers.   Specifically,   studies   have   used   contraction-­induced  
injury  to  determine  effects  of  P188  on  skeletal  muscle  (25).  In  vivo,  the  effects  of  P188  
have  been  investigated  with  electroporation  injury  in  mice.  Results  of  this  study  suggest  
that   intravenous  injection  of  P188  can  facilitate  recovery  of  muscles  after   injury   in  vivo  
(15).  Similar  experiments  could  be  used  to  investigate  the  effects  of  other  poloxamers  in  
vivo,  specifically  in  mdx  mice.  
Additionally,  new  poloxamers  could  be  synthesized  with  a  similar  general  structure,  but  
different  variations  in  the  number  of  POP  and  POE  repeats.  It  would  be  particularly  useful  
to  obtain  poloxamers  with  more  varied  ratios  of  POP  to  POE.  For  example,  no  poloxamers  
were  examined  with  a  POE  weight  %  of  less  than  30%  and  a  POP  molecular  weight  above  
2500  g/mol  (fig  1A).  There  were  also  no  poloxamers  tested  with  either  50%  or  60%  POE  
by  weight.  Synthesizing  and  testing  more  poloxamers  in  these  regions  could  help  further  





With  many  groups  investigating  the  membrane  resealing  effects  of  P188,  it  is  important  
to   understand   the   effects   of   other   poloxamers   in   the   P188   family.   The   structural  
similarities  between  P188  and  other  poloxamers  in  the  P188  family  make  these  polymers  
good   potential   candidates   for   improving   resealing   capacity   in  multiple   cell   types.  Our  
results   suggest   that   poloxamers   with   intermediate   POP   and   POE   lengths   are   most  
effective  at  improving  membrane  repair  across  multiple  cell  types.  Poloxamers  with  either  
longer  or  shorter  POP  and  POE  chains  seemed  to  improve  membrane  repair  in  a  more  
cell-­type   dependent   manner.   The   largest   poloxamer   tested,   P338,   was   the   only  
poloxamer   to  show  no  signs  of   improving  membrane  repair  capacity   in  either  HEK293  
cells  or  mdx  muscle  fibers.  Overall,  results  suggest  that  there  are  multiple  poloxamers  in  
the  P188  family  that  have  the  ability  to  improve  membrane  repair  capacity.  To  determine  
the  potential  of  these  poloxamers  as  therapeutics,  future  investigations  should  continue  
to  evaluate  these  polymers,  and  others,  in  in  vivo  models  of  muscular  dystrophy.  




     
Figure  1.  A.  General  structure  of  a  poloxamer.  This  image  shows  the  molecular  makeup  of  a  poloxamer,  with  two  
chains  of  polyoxyethylene  (POE)  flanking  a  chain  of  polyoxypropylene  (POP)  B.    Poloxamer  Grid.  This  is  a  visual  
representation  of  how  different  poloxamers  compare  to  each  other.  Poloxamers  are  characterized  by  the  weight  
%  of  the  POE  chain  and  the  molecular  weight  of  the  POP  chain.  C.  Structure  of  Poloxamers  Screened.  This  table  
gives  an  overview  of  the  size  and  physical  properties  of  each  poloxamer,  including  molecular  weight  and  the  size  
of  both  the  POE  (a)  repeats  and  the  POP  (b)  repeats.  
	   	  
Figure  2.  A.  Diagram  depicting  rotation  damage  assay.  HEK293  cells  are  cultured  overnight  in  2mL  microtubes  
to  allow  attachment  to  the  bottom  of  the  tube.    The  cells  are  washed  with  PBS  and  20  µL  of  small  glass  beads  
(≤106μm)  are  added  to  each  sample.  Tubes  are  rotated  15  times  at  a  rate  of  1  revolution  per  4  seconds  to  
damage  the  samples.  15  µL  of  the  supernatant  is  collected  and  the  amount  of  leaked  LDH  released  is  
measured.  Each  of  the  samples  are  normalized  by  the  total  LDH  release  produced  by  triton  detergent.  B.  
Results  of  the  rotation  damage  assay,  showing  the  absorbance  at  a  wavelength  of  490  after  an  LDH  test  was  
performed  on  the  supernatant  as  described  in  figure  2A.  Graph  shows  mean  with  SEM.  Analysis  by  one  way  
ANOVA  comparing  to  the  15  rotation  control.  *P  ≤  0.05  by  ANOVA,  **P  ≤  0.003  by  ANOVA,  ****P  ≤  0.0001  by  
ANOVA,  #P  >  0.05  by  ANOVA,  n=12-­42    
	   	  
Figure  3.  A.  Results  of  laser  injury  assay  performed  in  extensor  digitorum  longus  (EDL)  muscles  of  mdx  mice,  
when  exposed  to  poloxamers  with  less  than  50%  POE  by  weight.  All  curves  represent  fluorescence  after  injury  
while  muscle  was  in  1X  Tyrode’s  solution  with  2mM  Ca	  "#  and  100µM  poloxamer.  Graph  depicts  change  in  
fluorescence  of  a  lipophilic  dye,  (FM4-­64)  over  time  at  the  injury  site  with  SEM.  B.  Area  Under  the  Curve  (AUC)  
for  the  laser  injury  graph  in  figure  3A.  Graph  depicts  mean  with  SEM.  Analysis  by  one  way  ANOVA  comparing  
to  the  no  poloxamer  control.  *P  ≤  0.05  by  ANOVA,  **P  ≤  0.003  by  ANOVA,  ****P  ≤  0.0001  by  ANOVA,  n=7-­48  
C.  Representative  images  of  muscle  fibers  before  and  45  seconds  after  injury  with  multiphoton  laser.    
	   	  
Figure  4.  A.  Results  of  laser  injury  assay  performed  in  extensor  digitorum  longus  (EDL)  muscles  of  mdx  
mice,  when  exposed  to  poloxamers  with  more  than  50%  POE  by  weight.  All  curves  represent  fluorescence  
after  injury  while  muscle  was  in  1X  Tyrode’s  solution  with  2mM  Ca	  "#  and  100µM  poloxamer.  Graph  depicts  
change  in  fluorescence  over  time  of  a  lipophilic  dye,  FM4-­64,  with  SEM.  B.  Area  Under  the  Curve  (AUC)  for  
the  laser  injury  graph  in  figure  4A.  Graph  depicts  mean  with  SEM.  Analysis  by  one  way  ANOVA  comparing  to  
the  no  poloxamer  control.  ****P  ≤  0.0001  by  ANOVA,  #P  >  0.05  by  ANOVA,  n=7-­48  C.  Representative  
images  of  muscle  fibers  before  and  45  seconds  after  injury  with  multiphoton  laser.    
	  Figure  5.  A.  Results  of  laser  injury  assay  performed  in  human  embryonic  kidney  (HEK)  cells,  when  exposed  
to  poloxamers  P188  and  P108.  All  curves  represent  fluorescence  after  injury  while  cells  were  in  1X  Tyrode’s  
solution  with  2mM  Ca	  "#  and  100µM  poloxamer.  Graph  depicts  change  in  fluorescence  over  time  of  a  
lipophilic  dye,  FM4-­64,  with  SEM.  B.  Area  Under  the  Curve  (AUC)  for  the  laser  injury  graph  in  figure  5A.  
Graph  depicts  mean  with  SEM.  Analysis  by  one  way  ANOVA  comparing  to  the  no  poloxamer  control.  ****P  
≤  0.0001  by  ANOVA,  #P  >  0.05  by  ANOVA,  n=6-­11  C.  Representative  images  of  cells  before  and  45  
seconds  after  injury  with  multiphoton  laser.    
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